Pentwater Capital Management Adds $41M in Surgery Partners, Inc. ($SGRY)
Key Points
- Pentwater Capital Management changed its Surgery Partners, Inc. ($SGRY) stake by 26.6% last quarter, boosting to 12,655,000 shares worth $193.75 million.
- Wall Street's consensus rating on $SGRY is Buy and an average price target of $17.95.
- $SGRY last traded around $15.31.
Pentwater Capital Management increased its position in Surgery Partners, Inc. ($SGRY) by 26.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,655,000 shares of Surgery Partners, Inc. after buying 2,655,000 shares during the quarter. Pentwater Capital Management's holdings in Surgery Partners, Inc. were worth $193.75 million as of its most recent filing.
Surgery Partners, Inc. ($SGRY) Stock
Surgery Partners, Inc. Earnings
Analysts Set New Price Targets
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.